The present study showed that serum levels and hepatic expression of NLRP3 increased progressively with increasing severity of liver necroinflammation and were positively correlated with serum aminotransferase levels and histological activity grade (markers of hepatic necroinflammation) in patients with HCV-related liver disease. Here, NLRP3 is linked to liver disorder.